Skip to content
  • NMAC Job Openings
  • Join Our FREE Mailing List
  • USCHA
  • Summit
  • This icon serves as a link to download the eSSENTIAL Accessibility assistive technology app for individuals with physical disabilities. It is featured as part of our commitment to diversity and inclusion.
  •  call us
  • info@nmac.org

NMAC NMAC

Donate
  • Who We Are
    • Leading With Race / Mission
    • Board of Directors
    • Staff
    • Constituent Advisory Panels
      • African American CAP
      • American Indian and Alaskan Native CAP
      • Asian CAP
      • Latinx CAP
      • Native Hawaiian and Pacific Islander CAP
      • TGNCB CAP
    • NMAC Job Opportunities
    • Financial Information
    • Calendar of Events
    • Privacy Policy
  • Programs
    • NMAC’s Treatment Division
    • NMAC Training Center to End the HIV Epidemic in America
      • ESCALATE
      • ELEVATE
      • BLOC
      • Youth Initiative
      • Youth HIV Navigation Resource for HIV Navigators
      • The ETE Workforce
      • HIV-E
    • Coalition for Justice and Equality Across Movements
  • Public Policy
    • Advocacy 101
    • Current Legislation
  • Resource Library
    • Newsletters
    • Publications
    • Resources
      • COVID-19 Resources
    • Blog
    • Webinar Library
    • Podcasts
  • Supporting NMAC
    • Membership
    • Other Ways to Give
    • Donate
  • Conferences
    • 2023 USCHA
    • Biomedical HIV Prevention Summit
  • Contact Us
    • Social Media
      • Facebook
      • Twitter
      • YouTube
      • Instagram
    • Join Mailing List
  • Who We Are
    • Leading With Race / Mission
    • Board of Directors
    • Staff
    • Constituent Advisory Panels
      • African American CAP
      • American Indian and Alaskan Native CAP
      • Asian CAP
      • Latinx CAP
      • Native Hawaiian and Pacific Islander CAP
      • TGNCB CAP
    • NMAC Job Opportunities
    • Financial Information
    • Calendar of Events
    • Privacy Policy
  • Programs
    • NMAC’s Treatment Division
    • NMAC Training Center to End the HIV Epidemic in America
      • ESCALATE
      • ELEVATE
      • BLOC
      • Youth Initiative
      • Youth HIV Navigation Resource for HIV Navigators
      • The ETE Workforce
      • HIV-E
    • Coalition for Justice and Equality Across Movements
  • Public Policy
    • Advocacy 101
    • Current Legislation
  • Resource Library
    • Newsletters
    • Publications
    • Resources
      • COVID-19 Resources
    • Blog
    • Webinar Library
    • Podcasts
  • Supporting NMAC
    • Membership
    • Other Ways to Give
    • Donate
  • Conferences
    • 2023 USCHA
    • Biomedical HIV Prevention Summit
  • Contact Us
    • Social Media
      • Facebook
      • Twitter
      • YouTube
      • Instagram
    • Join Mailing List

Category: HIV and Health Policy Update

  • Home
  • HIV and Health Policy Update
Important Happenings in HIV/Health Policy 8/1/19

Important Happenings in HIV/Health Policy 8/1/19

  • July 31, 2019
  • NMAC
  • Blog, HIV and Health Policy Update
  • Comments are Closed

House Oversight Committee to Hold Hearing on Gilead’s Exorbitant Price for 
HIV Prevention Drug – On Thursday, May 16, 2019, at 10:00 a.m., the Committee on Oversight and Reform will hold a hearing on “HIV Prevention Drug: Billions in Corporate Profits after Millions in Taxpayer Investments.”

Important Happenings in HIV/Health Policy 6/21/19

Important Happenings in HIV/Health Policy 6/21/19

  • June 26, 2019
  • NMAC
  • Blog, HIV and Health Policy Update
  • Comments are Closed

House Oversight Committee to Hold Hearing on Gilead’s Exorbitant Price for 
HIV Prevention Drug – On Thursday, May 16, 2019, at 10:00 a.m., the Committee on Oversight and Reform will hold a hearing on “HIV Prevention Drug: Billions in Corporate Profits after Millions in Taxpayer Investments.”

Important Happenings in HIV/Health Policy 6/14/19

Important Happenings in HIV/Health Policy 6/14/19

  • June 19, 2019
  • NMAC
  • Blog, HIV and Health Policy Update
  • Comments are Closed

House Oversight Committee to Hold Hearing on Gilead’s Exorbitant Price for 
HIV Prevention Drug – On Thursday, May 16, 2019, at 10:00 a.m., the Committee on Oversight and Reform will hold a hearing on “HIV Prevention Drug: Billions in Corporate Profits after Millions in Taxpayer Investments.”

Important Happenings in HIV/Health Policy 6/7/19

Important Happenings in HIV/Health Policy 6/7/19

  • June 12, 2019
  • NMAC
  • Blog, HIV and Health Policy Update
  • Comments are Closed

House Oversight Committee to Hold Hearing on Gilead’s Exorbitant Price for 
HIV Prevention Drug – On Thursday, May 16, 2019, at 10:00 a.m., the Committee on Oversight and Reform will hold a hearing on “HIV Prevention Drug: Billions in Corporate Profits after Millions in Taxpayer Investments.”

Important Happenings in HIV/Health Policy 5/31/19

Important Happenings in HIV/Health Policy 5/31/19

  • June 5, 2019
  • NMAC
  • Blog, HIV and Health Policy Update
  • Comments are Closed

House Oversight Committee to Hold Hearing on Gilead’s Exorbitant Price for 
HIV Prevention Drug – On Thursday, May 16, 2019, at 10:00 a.m., the Committee on Oversight and Reform will hold a hearing on “HIV Prevention Drug: Billions in Corporate Profits after Millions in Taxpayer Investments.”

Important Happenings in HIV/Health Policy

Important Happenings in HIV/Health Policy

  • May 22, 2019
  • NMAC
  • Blog, HIV and Health Policy Update
  • Comments are Closed

House Oversight Committee to Hold Hearing on Gilead’s Exorbitant Price for 
HIV Prevention Drug – On Thursday, May 16, 2019, at 10:00 a.m., the Committee on Oversight and Reform will hold a hearing on “HIV Prevention Drug: Billions in Corporate Profits after Millions in Taxpayer Investments.”

Important Happenings in HIV/Health Policy

Important Happenings in HIV/Health Policy

  • May 15, 2019
  • NMAC
  • Blog, HIV and Health Policy Update
  • Comments are Closed

House Oversight Committee to Hold Hearing on Gilead’s Exorbitant Price for 
HIV Prevention Drug – On Thursday, May 16, 2019, at 10:00 a.m., the Committee on Oversight and Reform will hold a hearing on “HIV Prevention Drug: Billions in Corporate Profits after Millions in Taxpayer Investments.”

Important Happenings in HIV/Health Policy

Important Happenings in HIV/Health Policy

  • May 8, 2019
  • NMAC
  • Blog, HIV and Health Policy Update
  • Comments are Closed

FY20 House Labor-HHS Appropriations Summary (Upcoming Fiscal Year) – On April 29, 2019, the House Appropriations Committee released the draft fiscal year 2020 (FY20) Labor, Health and Human Services, Education, and Related Agencies (LHHS) funding bill, which included the following funds for federal HIV programs

Important Happenings in HIV/Health Policy

Important Happenings in HIV/Health Policy

  • April 17, 2019
  • NMAC
  • Blog, HIV and Health Policy Update
  • Comments are Closed
Week ending: April 12, 2019 By: Sable K. Nelson HIV Rates Are Rising Across the American South in States That Didn't Expand Medicaid Dramatically reducing HIV infections in the next [...]
Important Happenings in HIV/Health Policy

Important Happenings in HIV/Health Policy

  • April 11, 2019
  • NMAC
  • Blog, HIV and Health Policy Update
  • Comments are Closed

Week ending: April 5, 2019 By: Sable K. Nelson Gilead Submits Supplemental New Drug Application to U.S. Food and Drug Administration for Once-Daily Descovy for HIV Pre-Exposure Prophylaxis On April […]

  • 1
  • 2
  • 3
  • Next

Subscribe Newsletter

  • This field is for validation purposes and should be left unchanged.
NMAC

 

1000 Vermont Avenue, NW, Suite 200
Washington DC 20005-4903
Email: communications@nmac.org
Phone: (202) 744-6517

Charity Navigator - Four Star Charity

© 2022 NMAC. Design denson design / Development DMS • Privacy Policy

How much would you like to donate?